Fatal consequences of a simple mistake: How can a patient be saved from inadvertent intrathecal vincristine?
Authors:
- G. Kesava ReddyGRG. Kesava Reddy
- Benjamin BrownBBBenjamin Brown
- Anil NandaANAnil Nanda
- 1 January 2011
- journal article
- case report
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 113 (1) , 68-71
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Inadvertent intrathecal administration of vincristineCommunity Oncology, 2007
- Preventing intrathecal administration of vincristineMedical Journal of Australia, 2004
- 1. Accidental Intraventricular Vincristine Administration: An Avoidable Iatrogenic DeathMedicine, Science and the Law, 1996
- Fatal myeloencephalopathy due to intrathecal vincristine administrationPaediatrics and International Child Health, 1992
- Prolonged Survival Following the Inadvertent Intrathecal Administration of VincristineClinical Neuropharmacology, 1991
- Intrathecal vincristine. Report of a fatal case despite CNS washoutCancer, 1983
- Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic errorCancer, 1983
- Accidental intrathecal vincristine administrationJournal of Neurology, 1982
- Fatal myeloencephalopathy caused by intrathecal vincristineNeurology, 1980
- Accidental intrathecal administration of vincristineMedical and Pediatric Oncology, 1978